Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Publication year range
1.
Zhong Xi Yi Jie He Xue Bao ; 3(5): 370-3, 2005 Sep.
Article in Chinese | MEDLINE | ID: mdl-16159571

ABSTRACT

OBJECTIVE: To observe the effects of recipes for replenishing qi and activating blood on p16, p21, proliferating cell nuclear antigen (PCNA), cyclin D1 and cyclin E gene expressions in the liver of aging rats. METHODS: A recipe for replenishing qi and a recipe for activating blood were administered to aging rats respectively, and the effects of the above recipes on the expressions of senescence related genes (p16, p21, PCNA, cyclin D1 and cyclin E) were examined by RT-PCR and Western blotting methods. RESULTS: The expressions of p16, p21 and cyclin D1 mRNAs and proteins in the liver of the untreated aging rats were up-regulated, while the expressions of PCNA and cyclin E mRNAs and proteins decreased. As compared with the untreated aging rats, both recipes could down-regulate the expressions of cyclin D1 mRNA and protein and up-regulate the expressions of cyclin E mRNA and protein, but had no obvious effects on the expressions of mRNAs and proteins of p16, p21 and PCNA. CONCLUSION: Recipes for replenishing qi and activating blood can improve the liver cell proliferation of aging rats via down-regulating the expressions of cyclin D1 mRNA and protein and up-regulating the expressions of cyclin E mRNA and protein.


Subject(s)
Aging/genetics , Drugs, Chinese Herbal/pharmacology , Liver/metabolism , Proliferating Cell Nuclear Antigen/biosynthesis , Animals , Cellular Senescence , Cyclin D1/biosynthesis , Cyclin D1/genetics , Cyclin-Dependent Kinase Inhibitor p16/biosynthesis , Cyclin-Dependent Kinase Inhibitor p16/genetics , Gene Expression , Male , Proliferating Cell Nuclear Antigen/genetics , Proto-Oncogene Proteins p21(ras)/biosynthesis , Proto-Oncogene Proteins p21(ras)/genetics , RNA, Messenger/biosynthesis , RNA, Messenger/genetics , Rats , Rats, Sprague-Dawley
2.
Biochem Biophys Res Commun ; 321(3): 736-45, 2004 Aug 27.
Article in English | MEDLINE | ID: mdl-15358168

ABSTRACT

We previously blocked the heat shock transcription factor 1 function with a dominant-negative mutant (mHSF1) in breast cancer cell line Bcap37, and found that mHSF1 sensitizes Bcap37 cells to hyperthermia by promoting the apoptotic process. Here we studied the mechanism of this abolishing process and how thermotolerance develops in Bcap37 cells. The results indicated that mHSF1 abolished acquired or intrinsic thermotolerance in Bcap37 cells by enhancing JNK and caspase-3 pathways, two stress-induced apoptotic pathways, after hyperthermia, and interference with either one of them attenuated hyperthermia-induced apoptosis. Furthermore, epistasis assay of these two pathways suggested that JNK was upstream of the caspase-3 pathway. Conversely, other hyperthermia-induced kinases implicated in cell survival and death, Akt, ERK or p38, did not influence the effect of mHSF1, indicating that these kinases were not implicated in this abolishing process. In addition, we found that the development of acquired thermotolerance of Bcap37 cells was associated with the suppression of JNK activation after mild preheat treatment and was not reduced by Akt, ERK or p38 inhibition. In contrast, the intrinsic thermotolerance of Bcap37 cells was due to the intrinsic high levels of Akt and ERK activities since Akt or ERK inhibition resulted in increased thermosensitivity of Bcap37 cells. Our results suggest that mHSF1 plays a valuable role in the thermotolerance abolishment of Bcap37 cells, which likely contributes to tumor therapy in combination with hyperthermia.


Subject(s)
Caspases/metabolism , DNA-Binding Proteins/metabolism , Hot Temperature , Mitogen-Activated Protein Kinases/metabolism , Neoplasms/metabolism , Apoptosis/physiology , Breast Neoplasms/metabolism , Caspase 3 , Cell Line, Tumor , DNA-Binding Proteins/genetics , Enzyme Activation , Female , Heat Shock Transcription Factors , Humans , JNK Mitogen-Activated Protein Kinases , Mutation , Prohibitins , Signal Transduction/physiology , Transcription Factors
3.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-248449

ABSTRACT

<p><b>OBJECTIVE</b>To investigate hereditary susceptibility to coronary heart disease (CHD) in apolipoprotein E(apo E) and apo B polymorphisms of youths.</p><p><b>METHODS</b>Polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) was used to analyze apoE, apoB Xba I, apoB 3' variable number of tandem repeat (VNTR) genotypes for 244 healthy Han students (among them were 109 students with positive CHD family history).</p><p><b>RESULTS</b>The allele frequencies of apo e4, XbaI x(+), 3'VNTR-B(hypervariable element, HVE>38) in the positive group were obviously higher than those in the negative group(P<0.05), and were significantly correlated with the increase in TC, LDL-C, apoB100 levels (P<0.05).</p><p><b>CONCLUSION</b>The alleles for apo e4, XbaI x(+), 3'VNTR-B may be the important genetic markers of Han CHD.</p>


Subject(s)
Adolescent , Female , Humans , Male , Young Adult , Alleles , Apolipoproteins B , Genetics , Apolipoproteins E , Genetics , Coronary Disease , Genetics , Gene Frequency , Polymerase Chain Reaction , Polymorphism, Genetic
4.
Neuroreport ; 13(6): 791-4, 2002 May 07.
Article in English | MEDLINE | ID: mdl-11997688

ABSTRACT

The antinociceptive effect of interleukin-2 gene on rat carrageenan-induced pain was explored using different delivery methods. Intrathecal (i.t.) or plantar s.c. delivery of plasmid harbouring the interleukin-2 gene produced a marked antinociceptive effect, which was maintained up to 6 days; the administration of recombinant human interleukin-2 only had a transitory effect. The antinociceptive effect lasted longer and was more potent when the interleukin-2 gene was administered i.t. than when delivered s.c. The effect of the interleukin-2 gene was related to its protein expression, was dose dependent, and could be potentiated by liposome. The results suggest that the interleukin-2 gene has a good prospect for clinical use.


Subject(s)
Afferent Pathways/drug effects , Genetic Therapy/methods , Genetic Vectors/pharmacology , Interleukin-2/genetics , Nociceptors/drug effects , Pain/drug therapy , Posterior Horn Cells/drug effects , Afferent Pathways/metabolism , Animals , Cation Exchange Resins/pharmacology , DNA, Complementary/genetics , Dose-Response Relationship, Drug , Gene Expression/physiology , Genetic Vectors/genetics , Genetic Vectors/therapeutic use , Indicators and Reagents/pharmacology , Injections, Spinal/methods , Injections, Subcutaneous , Interleukin-2/pharmacology , Lipids/pharmacology , Male , Nociceptors/metabolism , Pain/genetics , Pain/metabolism , Plasmids/genetics , Plasmids/pharmacology , Plasmids/therapeutic use , Posterior Horn Cells/metabolism , Rats , Rats, Sprague-Dawley
5.
Biochem Biophys Res Commun ; 290(5): 1454-61, 2002 Feb 08.
Article in English | MEDLINE | ID: mdl-11820785

ABSTRACT

Heat shock protein 70 (HSP70), an antiapoptotic chaperon protein, is highly expressed in human breast tumors and renders them resistant to such therapy as hyperthermia. In the present study, we inhibited the expression of HSP70 by blocking the heat shock transcription factor 1 (HSF1) function with its dominant-negative mutant (mHSF1) in Bcap37 cells, a thermotolerant breast cancer cell line. Here we report that retrovirus-mediated transfer of mHSF1 led to massive cell death of Bcap37 after hyperthermia. mHSF1 sensitized Bcap37 cells to hyperthermia by promoting apoptosis induced by heat shock. We also examined the efficacy of mHSF1 gene therapy in the nude mouse. mHSF1 transfection led to diminution of tumor growth with hyperthermia therapy. Thus, disrupting HSF1 in combination with hyperthermia may open new possibilities for treatment of cancers that have acquired resistance to heat treatment.


Subject(s)
DNA-Binding Proteins/antagonists & inhibitors , DNA-Binding Proteins/genetics , Gene Deletion , Hyperthermia, Induced , Animals , Antineoplastic Agents/antagonists & inhibitors , Antineoplastic Agents/pharmacology , Antineoplastic Agents/therapeutic use , Apoptosis/genetics , Breast Neoplasms/metabolism , Breast Neoplasms/physiopathology , Breast Neoplasms/therapy , Breast Neoplasms/ultrastructure , Cell Death/genetics , DNA-Binding Proteins/physiology , DNA-Binding Proteins/therapeutic use , Female , HSP70 Heat-Shock Proteins/antagonists & inhibitors , HSP70 Heat-Shock Proteins/biosynthesis , Heat Shock Transcription Factors , Humans , Mice , Mice, Nude , Microscopy, Electron , Neoplasm Transplantation , Prohibitins , Transcription Factors , Tumor Cells, Cultured/metabolism , Tumor Cells, Cultured/pathology , Tumor Cells, Cultured/ultrastructure
SELECTION OF CITATIONS
SEARCH DETAIL
...